|
C7ORF28B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.94640000000491E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.71930000000464E-05 |
| Normal-vs-Stage2 |
1.204790E-01 |
| Normal-vs-Stage3 |
1.235580E-03 |
| Normal-vs-Stage4 |
4.456900E-03 |
| Stage1-vs-Stage2 |
6.658100E-02 |
| Stage1-vs-Stage3 |
6.613600E-01 |
| Stage1-vs-Stage4 |
9.611400E-01 |
| Stage2-vs-Stage3 |
1.985560E-01 |
| Stage2-vs-Stage4 |
2.143200E-01 |
| Stage3-vs-Stage4 |
8.134200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.044220E-03 |
| Normal-vs-AfricanAmerican |
6.765700E-02 |
| Normal-vs-Asian |
4.44950000000333E-05 |
| Caucasian-vs-AfricanAmerican |
7.952400E-01 |
| Caucasian-vs-Asian |
6.141800E-02 |
| AfricanAmerican-vs-Asian |
1.177180E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.442170E-04 |
| Normal-vs-Female |
2.752100E-04 |
| Male-vs-Female |
5.892000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.13109999999528E-05 |
| Normal-vs-Age(41-60Yrs) |
8.14340000000469E-05 |
| Normal-vs-Age(61-80Yrs) |
4.469700E-02 |
| Normal-vs-Age(81-100Yrs) |
2.753900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.674800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.413700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.973800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.031780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.637200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.898400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.220200E-01 |
| Classical-VS-Follicular |
7.808000E-01 |
| Classical-VS-Other |
9.905000E-01 |
| Classical-VS-Normal |
1.781470E-04 |
| Tall-VS-Follicular |
7.108800E-01 |
| Tall-VS-Other |
7.729200E-01 |
| Tall-VS-Normal |
6.402400E-02 |
| Follicular-VS-Other |
9.270800E-01 |
| Follicular-VS-Normal |
6.262200E-03 |
| Other-VS-Normal |
1.695040E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.153900E-04 |
| Normal-vs-N1 |
3.350500E-04 |
| N0-vs-N1 |
1.454410E-01 |
|
|
